GPT and metabolic dysfunction-associated steatotic liver disease: Although the serum levels of ALT (P = 0.002), AST (P = 0.018),and GGT (P < 0.001) decreased significantly in the PRP group, between-group differences were not significant for these parameters (data are reported in our previously published article).48 However, the NAFLD fibrosis score improved significantly in the PRP group compared to the placebo group after adjusting for confounding factors (P = 0.021).